DualityBio has licensed its DUPAC next-generation ADC payload platform to Genentech, receiving a $45 million upfront payment plus over $1 billion in potential milestones.
#DualityBio #Biotech #Biotechnology #Health
Disclaimer: This is NOT a financial advice.
DualityBio has licensed its DUPAC next-generation ADC payload platform to Genentech, receiving a $45 million upfront payment plus over $1 billion in potential milestones. #DualityBio #Biotech #Biotechnology #Health Disclaimer: This is NOT a financial advice.
0 views
Published on 01/09/2026 13:09
DualityBio has licensed its DUPAC next-generation ADC payload platform to Genentech, receiving a $45 million upfront payment plus over $1 billion in potential milestones.
#DualityBio #Biotech #Biotechnology #Health
Disclaimer: This is NOT a financial advice.
0 comments
?